Lv3
290 积分 2022-11-11 加入
Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
8天前
已完结
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
1个月前
已完结
Once-weekly semaglutide 7· 2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
1个月前
已关闭
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
5个月前
已完结
Animal models for development of anti-obesity drugs in the Age of GLP-1 Agents
6个月前
已完结
Amylin takes another shot at the obesity prize
11个月前
已完结
皖公网安备34019202002308
